S&P 500   3,110.19 (-0.08%)
DOW   27,609.57 (-0.15%)
QQQ   202.27 (-0.08%)
AAPL   264.35 (+1.00%)
FB   198.82 (+0.06%)
MSFT   149.84 (+-0.01%)
GOOGL   1,318.04 (-0.07%)
AMZN   1,743.70 (-0.96%)
CGC   18.44 (+0.33%)
MU   46.36 (+0.13%)
BABA   199.91 (+3.18%)
GE   10.80 (-1.01%)
TSLA   330.31 (-0.82%)
T   38.29 (+0.47%)
AMD   39.74 (+0.13%)
ACB   2.44 (-1.61%)
F   8.90 (-0.56%)
BAC   33.06 (-0.27%)
DIS   147.99 (-0.20%)
S&P 500   3,110.19 (-0.08%)
DOW   27,609.57 (-0.15%)
QQQ   202.27 (-0.08%)
AAPL   264.35 (+1.00%)
FB   198.82 (+0.06%)
MSFT   149.84 (+-0.01%)
GOOGL   1,318.04 (-0.07%)
AMZN   1,743.70 (-0.96%)
CGC   18.44 (+0.33%)
MU   46.36 (+0.13%)
BABA   199.91 (+3.18%)
GE   10.80 (-1.01%)
TSLA   330.31 (-0.82%)
T   38.29 (+0.47%)
AMD   39.74 (+0.13%)
ACB   2.44 (-1.61%)
F   8.90 (-0.56%)
BAC   33.06 (-0.27%)
DIS   147.99 (-0.20%)
S&P 500   3,110.19 (-0.08%)
DOW   27,609.57 (-0.15%)
QQQ   202.27 (-0.08%)
AAPL   264.35 (+1.00%)
FB   198.82 (+0.06%)
MSFT   149.84 (+-0.01%)
GOOGL   1,318.04 (-0.07%)
AMZN   1,743.70 (-0.96%)
CGC   18.44 (+0.33%)
MU   46.36 (+0.13%)
BABA   199.91 (+3.18%)
GE   10.80 (-1.01%)
TSLA   330.31 (-0.82%)
T   38.29 (+0.47%)
AMD   39.74 (+0.13%)
ACB   2.44 (-1.61%)
F   8.90 (-0.56%)
BAC   33.06 (-0.27%)
DIS   147.99 (-0.20%)
S&P 500   3,110.19 (-0.08%)
DOW   27,609.57 (-0.15%)
QQQ   202.27 (-0.08%)
AAPL   264.35 (+1.00%)
FB   198.82 (+0.06%)
MSFT   149.84 (+-0.01%)
GOOGL   1,318.04 (-0.07%)
AMZN   1,743.70 (-0.96%)
CGC   18.44 (+0.33%)
MU   46.36 (+0.13%)
BABA   199.91 (+3.18%)
GE   10.80 (-1.01%)
TSLA   330.31 (-0.82%)
T   38.29 (+0.47%)
AMD   39.74 (+0.13%)
ACB   2.44 (-1.61%)
F   8.90 (-0.56%)
BAC   33.06 (-0.27%)
DIS   147.99 (-0.20%)
Log in

NASDAQ:IRMD - Iradimed Stock Price, Forecast & News

$22.59
+0.31 (+1.39 %)
(As of 12/5/2019 12:55 PM ET)
Today's Range
$22.38
Now: $22.59
$22.72
50-Day Range
$21.50
MA: $23.21
$25.46
52-Week Range
$16.68
Now: $22.59
$29.80
Volume1,601 shs
Average Volume67,803 shs
Market Capitalization$259.45 million
P/E Ratio52.53
Dividend YieldN/A
Beta1.49
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRMD
CUSIPN/A
Phone407-677-8022

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$30.44 million
Cash Flow$0.60 per share
Book Value$3.84 per share

Profitability

Net Income$6.30 million

Miscellaneous

Employees95
Market Cap$259.45 million
Next Earnings Date2/5/2020 (Estimated)
OptionableNot Optionable

Receive IRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.


Iradimed (NASDAQ:IRMD) Frequently Asked Questions

What is Iradimed's stock symbol?

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

How were Iradimed's earnings last quarter?

Iradimed Corp (NASDAQ:IRMD) issued its earnings results on Wednesday, October, 30th. The medical equipment provider reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.07. The medical equipment provider had revenue of $9.96 million for the quarter, compared to analyst estimates of $9.85 million. Iradimed had a net margin of 22.51% and a return on equity of 16.24%. View Iradimed's Earnings History.

When is Iradimed's next earnings date?

Iradimed is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Iradimed.

Has Iradimed been receiving favorable news coverage?

Headlines about IRMD stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Iradimed earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Iradimed.

Are investors shorting Iradimed?

Iradimed saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 448,000 shares, an increase of 9.6% from the September 30th total of 408,900 shares. Based on an average trading volume of 63,600 shares, the days-to-cover ratio is presently 7.0 days. Currently, 8.3% of the company's stock are sold short. View Iradimed's Current Options Chain.

Who are some of Iradimed's key competitors?

What other stocks do shareholders of Iradimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), Micron Technology (MU), Palo Alto Networks (PANW), BioTelemetry (BEAT), Alphabet (GOOG), IntriCon (IIN), Paypal (PYPL), GrubHub (GRUB) and Mastercard (MA).

Who are Iradimed's key executives?

Iradimed's management team includes the folowing people:
  • Mr. Roger E. Susi, Founder, Chairman, CEO & Pres (Age 66)
  • Mr. Christopher K. Scott, CFO & Sec. (Age 49)
  • Mr. John McCreery, Chief Operating Officer (Age 64)
  • Mr. Brent Johnson, Exec. VP of Worldwide Sales & Marketing (Age 60)
  • Mr. Louis Waldman, Controller (Age 64)

Who are Iradimed's major shareholders?

Iradimed's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Cadence Capital Management LLC (1.04%), Russell Investments Group Ltd. (0.63%), Roubaix Capital LLC (0.58%), State Street Corp (0.50%), Navellier & Associates Inc (0.25%) and Millennium Management LLC (0.19%). Company insiders that own Iradimed stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, Francis X Casey, John K Mccreery, Louis S Waldman, Monty K Allen, Roger E Susi and Steven M Nardi. View Institutional Ownership Trends for Iradimed.

Which institutional investors are selling Iradimed stock?

IRMD stock was sold by a variety of institutional investors in the last quarter, including Navellier & Associates Inc and Cadence Capital Management LLC. Company insiders that have sold Iradimed company stock in the last year include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen and Steven M Nardi. View Insider Buying and Selling for Iradimed.

Which institutional investors are buying Iradimed stock?

IRMD stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Roubaix Capital LLC, Millennium Management LLC, Squarepoint Ops LLC, Barclays PLC, State Street Corp and Tower Research Capital LLC TRC. View Insider Buying and Selling for Iradimed.

How do I buy shares of Iradimed?

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Iradimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $22.59.

How big of a company is Iradimed?

Iradimed has a market capitalization of $259.45 million and generates $30.44 million in revenue each year. The medical equipment provider earns $6.30 million in net income (profit) each year or $0.43 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

What is Iradimed's official website?

The official website for Iradimed is http://www.iradimed.com/.

How can I contact Iradimed?

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]


MarketBeat Community Rating for Iradimed (NASDAQ IRMD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  215 (Vote Outperform)
Underperform Votes:  220 (Vote Underperform)
Total Votes:  435
MarketBeat's community ratings are surveys of what our community members think about Iradimed and other stocks. Vote "Outperform" if you believe IRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Featured Article: Neutral Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel